[{"address1": "3957 Point Eden Way", "city": "Hayward", "state": "CA", "zip": "94545", "country": "United States", "phone": "510 906 4600", "website": "https://www.pulsebiosciences.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kevin P. Danahy", "age": 52, "title": "President & CEO", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 393246, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darrin R. Uecker", "age": 57, "title": "CTO & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 487235, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mitchell E. Levinson", "age": 63, "title": "Chief Strategy Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 361338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard  Nuccitelli Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth B.  Stratton Esq., J.D.", "age": 54, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patty  Perla", "title": "Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Danitz", "title": "Senior Vice President of Engineering", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gansevoort  Dunnington M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niv  Ad M.D.", "title": "Chief Science Officer of Cardiac Surgery", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1704067200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.7, "open": 8.73, "dayLow": 8.2, "dayHigh": 9.04, "regularMarketPreviousClose": 8.7, "regularMarketOpen": 8.73, "regularMarketDayLow": 8.2, "regularMarketDayHigh": 9.04, "beta": 1.731, "forwardPE": -9.377777, "volume": 224293, "regularMarketVolume": 224293, "averageVolume": 306433, "averageVolume10days": 232640, "averageDailyVolume10Day": 232640, "bidSize": 900, "askSize": 800, "marketCap": 464879392, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 13.62, "priceToSalesTrailing12Months": -51653.266, "fiftyDayAverage": 9.0814, "twoHundredDayAverage": 6.755225, "currency": "USD", "enterpriseValue": 423126144, "floatShares": 16258783, "sharesOutstanding": 55080500, "sharesShort": 2469455, "sharesShortPriorMonth": 2555823, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.0448, "heldPercentInsiders": 0.70555997, "heldPercentInstitutions": 0.07007, "shortRatio": 6.84, "shortPercentOfFloat": 0.1426, "impliedSharesOutstanding": 55080500, "bookValue": 0.948, "priceToBook": 8.902953, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -39474000, "trailingEps": -0.88, "forwardEps": -0.9, "enterpriseToRevenue": -47014.016, "enterpriseToEbitda": -10.977, "52WeekChange": 1.7102804, "SandP52WeekChange": 0.20233083, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PLSE", "underlyingSymbol": "PLSE", "shortName": "Pulse Biosciences, Inc", "longName": "Pulse Biosciences, Inc.", "firstTradeDateEpochUtc": 1463578200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "3b97af00-80b4-3c43-a8ac-8da7033e733c", "messageBoardId": "finmb_276735354", "gmtOffSetMilliseconds": -18000000, "currentPrice": 8.44, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 50386000, "totalCashPerShare": 0.916, "ebitda": -38547000, "totalDebt": 9384000, "quickRatio": 9.276, "currentRatio": 9.503, "totalRevenue": -9000, "debtToEquity": 17.996, "returnOnAssets": -0.32396, "returnOnEquity": -1.35338, "freeCashflow": -20587750, "operatingCashflow": -34224000, "operatingMargins": 4420.6665, "financialCurrency": "USD", "trailingPegRatio": null}]